Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Parkinson's Disease

  Free Subscription

Articles published in Neurosci Lett

Retrieve available abstracts of 127 articles:
HTML format

Single Articles

    June 2022
  1. XU B, Wang X, Xu Z, Li Q, et al
    N-cystaminylbiguanide MC001 prevents neuron cell death and alleviates motor deficits in the MPTP-model of Parkinson's disease.
    Neurosci Lett. 2022 Jun 20:136751. doi: 10.1016/j.neulet.2022.136751.
    PubMed     Abstract available

  2. LI C, Hou B, Li X, Yang Z, et al
    Role of CD36 rs1761667 AA genotype in the expression of inflammatory cytokines and Parkinson's disease progression: A case-control study in a northern Han Chinese population.
    Neurosci Lett. 2022;784:136736.
    PubMed     Abstract available

  3. SHI X, Zheng J, Ma J, Wang Z, et al
    Insulin-like growth factor in Parkinson's disease is related to nonmotor symptoms and the volume of specific brain areas.
    Neurosci Lett. 2022;783:136735.
    PubMed     Abstract available

  4. YANG Z, Xue L, Li C, Li M, et al
    Association between ABCA7 gene polymorphisms and Parkinson's disease susceptibility in a northern Chinese Han population.
    Neurosci Lett. 2022;784:136734.
    PubMed     Abstract available

    May 2022
  5. WANG LX, Liu C, Shao YQ, Jin H, et al
    Peripheral Blood Inflammatory Cytokines are Associated with Rapid Eye Movement Sleep Behavior Disorder in Parkinson's Disease.
    Neurosci Lett. 2022 May 20:136692. doi: 10.1016/j.neulet.2022.136692.
    PubMed     Abstract available

  6. SHKODINA AD, Tarianyk KA, Boiko DI, Zehravi M, et al
    Cognitive and affective disturbances in patients with Parkinson's disease: perspectives for classifying of motor/neuropsychiatric subtypes.
    Neurosci Lett. 2022 May 6:136675. doi: 10.1016/j.neulet.2022.136675.
    PubMed     Abstract available

    April 2022
  7. ZHANG J, Wang M, Zhao Y, Zhang Y, et al
    Alpha-lipoic acid improved motor function in MPTP-induced Parkinsonian mice by reducing neuroinflammation in the nigral and spinal cord.
    Neurosci Lett. 2022;781:136669.
    PubMed     Abstract available

  8. LIM HS, Park G
    Resilin, an insect-derived elastomeric protein, protects dopaminergic neurons in Parkinson disease models.
    Neurosci Lett. 2022;781:136667.
    PubMed     Abstract available

  9. CHEN W, Hou C, Wang Y, Hong L, et al
    Circular RNA circTLK1 regulates dopaminergic neuron injury during Parkinson's disease by targeting miR-26a-5pDAPK1.
    Neurosci Lett. 2022 Apr 18:136638. doi: 10.1016/j.neulet.2022.136638.
    PubMed     Abstract available

    March 2022
  10. WANG Y, Luan M, Xue L, Jin J, et al
    Evaluation of the relationship between SORL1 gene polymorphism and Parkinson's disease in the Chinese population.
    Neurosci Lett. 2022;778:136602.
    PubMed     Abstract available

  11. NING P, Li K, Ren H, Yang H, et al
    Rare missense variants in the PPP2R5D gene associated with Parkinson's disease in the Han Chinese population.
    Neurosci Lett. 2022;776:136564.
    PubMed     Abstract available

    February 2022
  12. LUAN M, Jin J, Wang Y, Li X, et al
    Association of PGLYRP2 gene polymorphism and sporadic Parkinson's disease in northern Chinese Han population.
    Neurosci Lett. 2022;775:136547.
    PubMed     Abstract available

  13. COSTA TM, Simieli L, Bersotti FM, Mochizuki L, et al
    Gait and posture are correlated domains in Parkinson's disease.
    Neurosci Lett. 2022 Feb 19:136537. doi: 10.1016/j.neulet.2022.136537.
    PubMed     Abstract available

  14. NICHOLATOS JW, Tran D, Liu Y, Hirst WD, et al
    Lysophosphatidylcholine acyltransferase 1 promotes pathology and toxicity in two distinct cell-based alpha-synuclein models.
    Neurosci Lett. 2022;772:136491.
    PubMed     Abstract available

  15. WANG XL, Feng ST, Chen B, Hu D, et al
    Efficacy and safety of istradefylline for Parkinson's disease: A systematic review and meta-analysis.
    Neurosci Lett. 2022;774:136515.
    PubMed     Abstract available

    January 2022
  16. VIREL A, Johansson J, Axelsson J, Ericsson M, et al
    N-acetylcysteine decreases dopamine transporter availability in the non-lesioned striatum of the 6-OHDA hemiparkinsonian rat.
    Neurosci Lett. 2022;770:136420.
    PubMed     Abstract available

  17. ZHAO Y, Qi Y, Li Q, Quan H, et al
    Connexin43 inhibition attenuated dopaminergic neuronal loss in the lipopolysaccharide-induced mice model of Parkinson's disease.
    Neurosci Lett. 2022;771:136471.
    PubMed     Abstract available

  18. VITORINO LC, Oliveira KF, da Silva WAB, de Andrade Gomes CAB, et al
    Physical exercise influences astrocytes in the striatum of a Parkinson's disease male mouse model.
    Neurosci Lett. 2022;771:136466.
    PubMed     Abstract available

  19. AFSHARI D, Shakeri J, Khodamoradi M, Nejad Shahrokh Abadi R, et al
    Efficacy of electroconvulsive therapy in Parkinson's disease: a clinical trial.
    Neurosci Lett. 2022 Jan 10:136449. doi: 10.1016/j.neulet.2022.136449.
    PubMed     Abstract available

    December 2021
  20. OSTRAKHOVITCH EA, Song ES, Macedo JKA, Gentry MS, et al
    Analysis of circulating metabolites to differentiate Parkinson's disease and essential tremor.
    Neurosci Lett. 2021;769:136428.
    PubMed     Abstract available

  21. SANG T, He J, Wang J, Zhang C, et al
    Alterations in white matter fiber in Parkinson's disease across different cognitive stages.
    Neurosci Lett. 2021 Dec 24:136424. doi: 10.1016/j.neulet.2021.136424.

  22. LI Y, Li Z, Gu J, Xu X, et al
    Exosomes isolated during dopaminergic neuron differentiation suppressed neuronal inflammation in a rodent model of Parkinson's disease.
    Neurosci Lett. 2021;771:136414.
    PubMed     Abstract available

  23. PARK DG, Kang J, An YS, Chang J, et al
    Association of plasma alpha-synuclein with cardiac (123)I-MIBG scintigraphy in early Parkinson's disease.
    Neurosci Lett. 2021;770:136399.
    PubMed     Abstract available

    November 2021
  24. LI B, Yang S, Ye J, Chu S, et al
    Flavin-containing monooxygenase 1 deficiency promotes neuroinflammation in dopaminergic neurons in mice.
    Neurosci Lett. 2021;764:136222.
    PubMed     Abstract available

    October 2021
  25. PENGV B, Gong Z, Zhang Y, Shen B, et al
    Self-paced learning and privileged information Based KRR classification algorithm for diagnosis of Parkinson's disease.
    Neurosci Lett. 2021 Oct 29:136312. doi: 10.1016/j.neulet.2021.136312.
    PubMed     Abstract available

  26. BIAN K, Liu C, Wang Y, Xue Y, et al
    Orexin-B exerts excitatory effects on nigral dopaminergic neurons and alleviates motor disorders in MPTP parkinsonian mice.
    Neurosci Lett. 2021;765:136291.
    PubMed     Abstract available

  27. PANDI S, Chinniah R, Sevak V, Ravi PM, et al
    Association of HLA-DRB1, DQA1 and DQB1 alleles and haplotype in Parkinson's disease from South India.
    Neurosci Lett. 2021;765:136296.
    PubMed     Abstract available

    September 2021
  28. IKUNO M, Yamakado H, Amano I, Hatanaka Y, et al
    Mitochondrial Dysfunction in a Mouse Model of Prodromal Parkinson's Disease: A Metabolomic Analysis.
    Neurosci Lett. 2021 Sep 24:136267. doi: 10.1016/j.neulet.2021.136267.
    PubMed     Abstract available

  29. JIN JUNG Y, Choi H, Oh E
    Effects of particulate matter and nicotine for the MPP+-induced SH-SY5Y cells: Implication for Parkinson's disease.
    Neurosci Lett. 2021 Sep 23:136265. doi: 10.1016/j.neulet.2021.136265.

  30. POTTENGER AE, Bartlett MJ, Sherman SJ, Falk T, et al
    Evaluation of microglia in a rodent model of Parkinson's disease primed with L-DOPA after sub-anesthetic ketamine treatment.
    Neurosci Lett. 2021 Sep 15:136251. doi: 10.1016/j.neulet.2021.136251.
    PubMed     Abstract available

  31. PAULETTI C, Mannarelli D, Locuratolo N, Maffucci A, et al
    Serotonergic central tone in Parkinson's disease with fatigue: evidence from the loudness dependence of auditory evoked potentials (LDAEP).
    Neurosci Lett. 2021 Sep 9:136242. doi: 10.1016/j.neulet.2021.136242.
    PubMed     Abstract available

  32. CHUNG J, Ushakova A, Doitsidou M, Tzoulis C, et al
    The impact of common genetic variants in cognitive decline in the first seven years of Parkinson's disease: a longitudinal observational study.
    Neurosci Lett. 2021 Sep 9:136243. doi: 10.1016/j.neulet.2021.136243.
    PubMed     Abstract available

    August 2021
  33. MURATA T, Tochio N, Utsunomiya-Tate N
    Physicochemical characterization of the G51D mutation of alpha-synuclein that is responsible for its severe cytotoxicity.
    Neurosci Lett. 2021;760:136077.
    PubMed     Abstract available

  34. LIU Y, Huang Q, Wei Z, Ma S, et al
    GSK-3 mediates nuclear translocation of p62/SQSTM1 in MPTP-induced mouse model of Parkinson's disease.
    Neurosci Lett. 2021 Aug 13:136177. doi: 10.1016/j.neulet.2021.136177.
    PubMed     Abstract available

  35. TU HY, Gu YQ, Li X, Pei SF, et al
    Expression of autophagy related genes in peripheral blood cells in Parkinson's disease.
    Neurosci Lett. 2021 Aug 6:136166. doi: 10.1016/j.neulet.2021.136166.
    PubMed     Abstract available

  36. ZHENG R, Qiao S, Chen Y, Jin C, et al
    Association analysis and polygenic risk score evaluation of 38 GWAS-identified Loci in a Chinese population with Parkinson's disease.
    Neurosci Lett. 2021;762:136150.
    PubMed     Abstract available

  37. TANG C, Zhao X, Wu W, Zhong W, et al
    An individualized prediction of time to cognitive impairment in Parkinson's disease: a combined multi-predictor study.
    Neurosci Lett. 2021 Aug 2:136149. doi: 10.1016/j.neulet.2021.136149.
    PubMed     Abstract available

    July 2021
  38. SALJUQI M, Ghaderyan P
    A novel method based on matching pursuit decomposition of gait signals for Parkinson's disease, Amyotrophic lateral sclerosis and Huntington's disease detection.
    Neurosci Lett. 2021 Jul 10:136107. doi: 10.1016/j.neulet.2021.136107.
    PubMed     Abstract available

    June 2021
  39. BAI X, Dong Q, Zhao L, Yao Y, et al
    microRNA-106b-containing extracellular vesicles affect autophagy of neurons by regulating CDKN2B in Parkinson's disease.
    Neurosci Lett. 2021 Jun 30:136094. doi: 10.1016/j.neulet.2021.136094.
    PubMed     Abstract available

  40. DA SILVA WAB, Ferreira Oliveira K, Caroline Vitorino L, Ferreira Romao L, et al
    Physical exercise increases the production of tyrosine hydroxylase and CDNF in the spinal cord of a Parkinson's disease mouse model.
    Neurosci Lett. 2021 Jun 25:136089. doi: 10.1016/j.neulet.2021.136089.
    PubMed     Abstract available

  41. SUN D, Wu X, Xia Y, Wu F, et al
    Differentiating Parkinson's Disease Motor Subtypes: A Radiomics Analysis Based on Deep Gray Nuclear Lesion and White Matter.
    Neurosci Lett. 2021 Jun 23:136083. doi: 10.1016/j.neulet.2021.136083.
    PubMed     Abstract available

  42. YIN K, Zhou C, Yin L, Zhu Y, et al
    Resting-state functional magnetic resonance imaging of the cerebellar vermis in patients with Parkinson's disease and visuospatial disorder.
    Neurosci Lett. 2021;760:136082.
    PubMed     Abstract available

  43. XU X, He X, Ma S, Li M, et al
    Nurr1 downregulation is caused by CREB inactivation in a Parkinson's disease mouse model.
    Neurosci Lett. 2021;759:136045.
    PubMed     Abstract available

  44. NIYOMRAT K, Cheaha D, Nukitram J, Kumarnsit E, et al
    Locomotor activity and resting local field potential oscillatory rhythms of 6-OHDA mouse model of Parkinson's disease in response to acute and repeated treatments with L-dopa.
    Neurosci Lett. 2021 Jun 4:136007. doi: 10.1016/j.neulet.2021.136007.
    PubMed     Abstract available

    May 2021
  45. LI N, Suo X, Zhang J, Lei D, et al
    Disrupted functional brain network topology in Parkinson's disease patients with freezing of gait.
    Neurosci Lett. 2021 May 20:135970. doi: 10.1016/j.neulet.2021.135970.
    PubMed     Abstract available

  46. TAKAHASHI K, Iwaoka K, Takahashi K, Suzuki Y, et al
    Cerebrospinal fluid levels of oxidative stress measured using diacron-reactive oxygen metabolites and biological antioxidant potential in patients with Parkinson's disease and progressive supranuclear palsy.
    Neurosci Lett. 2021 May 20:135975. doi: 10.1016/j.neulet.2021.135975.
    PubMed     Abstract available

  47. RONG Z, Shen F, Wang Y, Sun L, et al
    Phosphorylated alpha-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis.
    Neurosci Lett. 2021;756:135964.
    PubMed     Abstract available

    April 2021
  48. VENKATESAN D, Iyer M, S RW, G L, et al
    The association between multiple risk factors, clinical correlations and molecular insights in Parkinson's disease patients from Tamil Nadu population, India.
    Neurosci Lett. 2021;755:135903.
    PubMed     Abstract available

  49. SALAS-LEAL AC, Salas-Pacheco SM, Gavilan-Ceniceros JAP, Castellanos-Juarez FX, et al
    alpha-syn and SNP rs356219 as a potential biomarker in blood for Parkinson's disease in Mexican Mestizos.
    Neurosci Lett. 2021;754:135901.
    PubMed     Abstract available

  50. ZHANG L, He Y, Lei K, Fang Z, et al
    Gene expression profiling of early Parkinson's disease patient reveals redox homeostasis.
    Neurosci Lett. 2021;753:135893.
    PubMed     Abstract available

  51. BAI X, Liu X, Li X, Li W, et al
    Association between VPS13C rs2414739 polymorphism and Parkinson's disease risk: A meta-analysis.
    Neurosci Lett. 2021 Apr 7:135879. doi: 10.1016/j.neulet.2021.135879.
    PubMed     Abstract available

  52. RAJ K, Kaur P, Gupta GD, Singh S, et al
    Metals associated neurodegeneration in Parkinson's disease: Insight to physiological, pathological mechanisms and management.
    Neurosci Lett. 2021;753:135873.
    PubMed     Abstract available

  53. KAKOTY V, K C S, Dubey SK, Yang CH, et al
    The gut-brain connection in the pathogenicity of Parkinson disease: Putative role of autophagy.
    Neurosci Lett. 2021;753:135865.
    PubMed     Abstract available

  54. WERNICK AI, Walton RL, Soto-Beasley AI, Koga S, et al
    Investigating ELOVL7 coding variants in multiple system atrophy.
    Neurosci Lett. 2021;749:135723.
    PubMed     Abstract available

    March 2021
  55. NAUSHAD SM, Hussain T, Alrokayan S, Kutala VK, et al
    Alpha synuclein (SNCA) rs7684318 variant contributes to Parkinson's disease risk by altering transcription factor binding related with Notch and Wnt signaling.
    Neurosci Lett. 2021 Mar 8:135802. doi: 10.1016/j.neulet.2021.135802.
    PubMed     Abstract available

    February 2021
  56. KAKOTY V, Sarathlal KC, Dubey SK, Yang CH, et al
    Lentiviral mediated gene delivery as an effective therapeutic approach for Parkinson disease.
    Neurosci Lett. 2021 Feb 23:135769. doi: 10.1016/j.neulet.2021.135769.
    PubMed     Abstract available

  57. SHARMA T, Kaur D, Grewal AK, Singh TG, et al
    Therapies modulating insulin resistance in Parkinson's disease: A cross talk.
    Neurosci Lett. 2021 Feb 18:135754. doi: 10.1016/j.neulet.2021.135754.
    PubMed     Abstract available

  58. SIOKAS V, Arseniou S, Aloizou AM, Tsouris Z, et al
    CD33 rs3865444 as a risk factor for Parkinson's disease.
    Neurosci Lett. 2021 Feb 11:135709. doi: 10.1016/j.neulet.2021.135709.
    PubMed     Abstract available

    January 2021
  59. GUO W, Jin W, Li N, Gao J, et al
    Brain activity alterations in patients with Parkinson's disease with cognitive impairment based on resting-state functional MRI.
    Neurosci Lett. 2021 Jan 27:135672. doi: 10.1016/j.neulet.2021.135672.
    PubMed     Abstract available

  60. LEE SH, Han YT, Cha DS
    Neuroprotective effect of damaurone D in a C. elegans model of Parkinson's Disease.
    Neurosci Lett. 2021 Jan 19:135623. doi: 10.1016/j.neulet.2021.135623.
    PubMed     Abstract available

  61. ZHANG L, Yang H
    Promotive effects of tetrahydroxystilbene glucoside on the differentiation of neural stem cells from the mesencephalon into dopaminergic neurons.
    Neurosci Lett. 2021;742:135520.
    PubMed     Abstract available

  62. DONG MX, Hu L, Wei YD, Chen GH, et al
    Metabolomics profiling reveals altered lipid metabolism and identifies a panel of lipid metabolites as biomarkers for Parkinson's disease related anxiety disorder.
    Neurosci Lett. 2021 Jan 10:135626. doi: 10.1016/j.neulet.2021.135626.
    PubMed     Abstract available

  63. TAGHIZADEH G, Joghataei MT, Goudarzi S, Bakhsheshi M, et al
    King's Parkinson's disease Pain Scale Cut-off Points for Detection of Pain Severity Levels: A Reliability and Validity Study.
    Neurosci Lett. 2021 Jan 8:135620. doi: 10.1016/j.neulet.2020.135620.
    PubMed     Abstract available

    December 2020
  64. YU LH, Peng GP, Yuan Y, Liu XY, et al
    Novel compound heterozygous of PARKIN causes early-onset Parkinson's disease.
    Neurosci Lett. 2020;744:135597.
    PubMed     Abstract available

    November 2020
  65. FLORES-SOTO ME, Corona-Angeles JA, Tejeda-Martinez AR, Flores-Guzman PA, et al
    Neurosci Lett. 2020 Nov 30:135534. doi: 10.1016/j.neulet.2020.135534.
    PubMed     Abstract available

  66. USENKO TS, Bezrukova AI, Bogdanova DA, Kopytova AE, et al
    Genetics variants and expression of the SCARB2 gene in the pathogenesis of Parkinson's disease in Russia.
    Neurosci Lett. 2020 Nov 20:135509. doi: 10.1016/j.neulet.2020.135509.
    PubMed     Abstract available

  67. WANG S, Zhang Y, Lei J, Guo S, et al
    Investigation of Sensorimotor Dysfunction in Parkinson Disease by Resting-state fMRI.
    Neurosci Lett. 2020 Nov 19:135512. doi: 10.1016/j.neulet.2020.135512.
    PubMed     Abstract available

  68. LI MG, Bian XB, Zhang J, Wang ZF, et al
    Aberrant Voxel-based Degree Centrality in Parkinson's Disease Patients with Mild Cognitive Impairment.
    Neurosci Lett. 2020 Nov 17:135507. doi: 10.1016/j.neulet.2020.135507.
    PubMed     Abstract available

  69. QI H, Shen D, Jiang C, Wang H, et al
    Ursodeoxycholic acid protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis in MPTP/MPP(+)-induced Parkinson's disease.
    Neurosci Lett. 2020 Nov 9:135493. doi: 10.1016/j.neulet.2020.135493.
    PubMed     Abstract available

  70. LIU Z, Ye Q, Wang F, Guo Y, et al
    Protective effect of thioredoxin reductase 1 in Parkinson's disease.
    Neurosci Lett. 2020 Nov 7:135457. doi: 10.1016/j.neulet.2020.135457.
    PubMed     Abstract available

  71. BALTUS THL, Morelli NR, de Farias CC, Trugilo KP, et al
    Association of -94 ATTG insertion/deletion NFkB1 and c.*126G>A NFkBIA genetic polymorphisms with oxidative and nitrosative stress biomarkers in Brazilian subjects with Parkinson's Disease.
    Neurosci Lett. 2020;740:135487.
    PubMed     Abstract available

  72. HUANG S, Zhao Z, Ma J, Hu S, et al
    Increased plasma orexin-A concentrations are associated with the Non-motor symptoms in Parkinson's disease patients.
    Neurosci Lett. 2020 Nov 5:135480. doi: 10.1016/j.neulet.2020.135480.
    PubMed     Abstract available

  73. YANG Q, Nanivadekar S, Taylor PA, Dou Z, et al
    Executive function network's white matter alterations relate to Parkinson's disease motor phenotype.
    Neurosci Lett. 2020 Nov 5:135486. doi: 10.1016/j.neulet.2020.135486.
    PubMed     Abstract available

    October 2020
  74. SAHAI S, Effendi ET, Mahoney EC, Tucker HR, et al
    Effects of subthalamic nucleus deep brain stimulation on neuronal spiking activity in the substantia nigra pars compacta in a rat model of Parkinson's disease.
    Neurosci Lett. 2020;739:135443.
    PubMed     Abstract available

  75. SONG MK, Lee JH, Kim J, Kim JH, et al
    Neuroprotective effect of NXP031 in the MPTP-induced Parkinson's disease model.
    Neurosci Lett. 2020 Oct 16:135425. doi: 10.1016/j.neulet.2020.135425.
    PubMed     Abstract available

  76. KESH S, Kannan RR, Sivaji K, Balakrishnan A, et al
    Hesperidin downregulates kinases lrrk2 and gsk3beta in a 6-OHDA induced Parkinson's disease model.
    Neurosci Lett. 2020 Oct 16:135426. doi: 10.1016/j.neulet.2020.135426.
    PubMed     Abstract available

    September 2020
  77. SUBRAMANIAN N, Ramanathan S, Venkatesan V, Koshy T, et al
    A Case-Control Association of RANTES (-28C >G) and CCR5-Delta32 Polymorphisms with Parkinson's Disease in Indians.
    Neurosci Lett. 2020 Sep 25:135404. doi: 10.1016/j.neulet.2020.135404.
    PubMed     Abstract available

  78. CANKARA FN, Gunaydin C, Bilge SS, Ozmen O, et al
    The neuroprotective action of lenalidomide on rotenone model of Parkinson's Disease: Neurotrophic and supportive actions in the substantia nigra pars compacta.
    Neurosci Lett. 2020;738:135308.
    PubMed     Abstract available

  79. YILMAZ NH, Calisoglu P, Guntekin B, Hanoglu L, et al
    Correlation between alpha activity and neuropsychometric tests in Parkinson's disease.
    Neurosci Lett. 2020;738:135346.
    PubMed     Abstract available

  80. SUN C, Jia G, Wang X, Wang Y, et al
    Immunoproteasome is up-regulated in rotenone-induced Parkinson's disease rat model.
    Neurosci Lett. 2020 Sep 6:135360. doi: 10.1016/j.neulet.2020.135360.
    PubMed     Abstract available

    August 2020
  81. QIU X, He H, Huang Y, Wang J, et al
    Genome-wide identification of m(6)A-associated single-nucleotide polymorphisms in Parkinson's disease.
    Neurosci Lett. 2020;737:135315.
    PubMed     Abstract available

  82. FATTAH A, Amiri F, Mohammadian M, Alipourfard I, et al
    Dysregulation of body antioxidant content is related to initiation and progression of Parkinson's disease.
    Neurosci Lett. 2020;736:135297.
    PubMed     Abstract available

    July 2020
  83. INOSE Y, Izumi Y, Yuki TT, Akaike A, et al
    Protective effects of Nrf2-ARE activator on dopaminergic neuronal loss in Parkinson disease model mice: Possible involvement of heme oxygenase-1.
    Neurosci Lett. 2020 Jul 23:135268. doi: 10.1016/j.neulet.2020.135268.
    PubMed     Abstract available

  84. JIN J, Xue L, Bai X, Zhang X, et al
    Association between epidermal growth factor receptor gene polymorphisms and susceptibility to Parkinson's disease.
    Neurosci Lett. 2020 Jul 23:135273. doi: 10.1016/j.neulet.2020.135273.
    PubMed     Abstract available

  85. JIN H, Gu HY, Mao CJ, Chen J, et al
    Association of inflammatory factors and aging in Parkinson's disease.
    Neurosci Lett. 2020 Jul 16:135259. doi: 10.1016/j.neulet.2020.135259.
    PubMed     Abstract available

  86. HUANG M, Wang Y, Wang L, Chen B, et al
    APOE rs405509 polymorphism and Parkinson's disease risk in the Chinese population.
    Neurosci Lett. 2020;736:135256.
    PubMed     Abstract available

  87. PANDI S, Chinniah R, Sevak V, Ravi PM, et al
    Association of slow acetylator genotype of N-acetyltransferase 2 with Parkinson's disease in south Indian population.
    Neurosci Lett. 2020;735:135260.
    PubMed     Abstract available

  88. GAO T, Zheng R, Ruan Y, Fang Y, et al
    Association of ZNF184, IL1R2, LRRK2, ITPKB, and PARK16 with sporadic Parkinson's disease in Eastern China.
    Neurosci Lett. 2020;735:135261.
    PubMed     Abstract available

  89. LI Z, Liu W, Xiao C, Wang X, et al
    Abnormal white matter microstructures in Parkinson's disease and comorbid depression: a whole-brain diffusion tensor imaging study.
    Neurosci Lett. 2020 Jul 6:135238. doi: 10.1016/j.neulet.2020.135238.
    PubMed     Abstract available

    June 2020
  90. MASIH A, Singh S, Agnihotri AK, Giri S, et al
    Design and development of 1,3,5-triazine-thiadiazole hybrids as potent adenosine A2A receptor (A2AR) antagonist for benefit in Parkinson's disease.
    Neurosci Lett. 2020;735:135222.
    PubMed     Abstract available

  91. ASLAN NS, Orhan G, Karahalil B
    The impacts of prominent gene polymorphisms in DNA repair enzymes on Parkinson's disease.
    Neurosci Lett. 2020;735:135203.
    PubMed     Abstract available

  92. AWOGBINDIN IO, Ishola IO, St-Pierre MK, Carrier M, et al
    Remodeling microglia to a protective phenotype in Parkinson's disease?
    Neurosci Lett. 2020 Jun 16:135164. doi: 10.1016/j.neulet.2020.135164.
    PubMed     Abstract available

    May 2020
  93. RUAN Y, Zheng R, Lin ZH, Gao T, et al
    Genetic analysis of arylsulfatase A (ARSA) in Chinese patients with Parkinson's disease.
    Neurosci Lett. 2020 May 26:135094. doi: 10.1016/j.neulet.2020.135094.
    PubMed     Abstract available

  94. JIA E, Pan M, Liu Z, Zhou Y, et al
    Transcriptomic profiling of differentially expressed genes and related pathways in different brain regions in Parkinson's disease.
    Neurosci Lett. 2020 May 21:135074. doi: 10.1016/j.neulet.2020.135074.
    PubMed     Abstract available

  95. CHEN H, Jin YH, Xue YY, Chen YL, et al
    Novel ATP13A2 and PINK1 variants identified in Chinese patients with Parkinson's disease by whole-exome sequencing.
    Neurosci Lett. 2020 May 21:135075. doi: 10.1016/j.neulet.2020.135075.
    PubMed     Abstract available

  96. LIU HJ, Li XY, Chen H, Yu HL, et al
    Identification of susceptibility loci for cognitive impairment in a cohort of Han Chinese patients with Parkinson's disease.
    Neurosci Lett. 2020 May 10:135034. doi: 10.1016/j.neulet.2020.135034.
    PubMed     Abstract available

    April 2020
  97. WANG J, Liu Y, Liu Y, Zhu K, et al
    The association between TLR3 rs3775290 polymorphism and sporadic Parkinson's disease in Chinese Han population.
    Neurosci Lett. 2020 Apr 23:135005. doi: 10.1016/j.neulet.2020.135005.
    PubMed     Abstract available

  98. QIU X, Huang Y, Cen L, Chen X, et al
    Association of GLP-1 receptor gene polymorphisms with sporadic Parkinson's disease in Chinese Han population.
    Neurosci Lett. 2020 Apr 22:135004. doi: 10.1016/j.neulet.2020.135004.
    PubMed     Abstract available

  99. JIN X, Li J, Li W, Wang X, et al
    Weighted gene co-expression network analysis reveals specific modules and biomarkers in Parkinson's Disease.
    Neurosci Lett. 2020 Apr 7:134950. doi: 10.1016/j.neulet.2020.134950.
    PubMed     Abstract available

  100. LENG B, Sun H, Zhao J, Liu Y, et al
    Plasma exosomal prion protein levels are correlated with cognitive decline in PD patients.
    Neurosci Lett. 2020;723:134866.
    PubMed     Abstract available

    March 2020
  101. KOSKI SK, Leino S, Panula P, Rannanpaa S, et al
    Genetic lack of histamine upregulates dopamine neurotransmission and alters rotational behavior but not levodopa-induced dyskinesia in a mouse model of Parkinson's disease.
    Neurosci Lett. 2020 Mar 26:134932. doi: 10.1016/j.neulet.2020.134932.
    PubMed     Abstract available

  102. XU X, Xiong S, Zhou X, Chen X, et al
    SAP97 polymorphisms is associated with early onset Parkinson's disease.
    Neurosci Lett. 2020 Mar 26:134931. doi: 10.1016/j.neulet.2020.134931.
    PubMed     Abstract available

  103. HU X, Mao C, Hu Z, Zhang Z, et al
    Association Analysis of 15 GWAS-linked Loci with Parkinson's Disease in Chinese Han Population.
    Neurosci Lett. 2020 Mar 9:134867. doi: 10.1016/j.neulet.2020.134867.
    PubMed     Abstract available

    February 2020
  104. ZHANG X, Xue L, Sun X, Jin J, et al
    Association of IL-16 gene polymorphisms with sporadic Parkinson's disease in a Han Chinese population.
    Neurosci Lett. 2020 Feb 28:134877. doi: 10.1016/j.neulet.2020.134877.
    PubMed     Abstract available

  105. SONG G, Xi G, Li Y, Zhao Y, et al
    Double triggers, nasal induction of a Parkinson's disease mouse model.
    Neurosci Lett. 2020;724:134869.
    PubMed     Abstract available

  106. WANG MD, Yao YN, Tang XC, Tang B, et al
    Reduced plasma progranulin levels are associated with the severity of Parkinson's disease.
    Neurosci Lett. 2020 Feb 26:134873. doi: 10.1016/j.neulet.2020.134873.
    PubMed     Abstract available

  107. FURLONG RM, O'Keeffe GW, O'Neill C, Sullivan AM, et al
    Alterations in alpha-synuclein and PINK1 expression reduce neurite length and induce mitochondrial fission and Golgi fragmentation in midbrain neurons.
    Neurosci Lett. 2020;720:134777.
    PubMed     Abstract available

  108. HANOGLU L, Saricaoglu M, Toprak G, Yilmaz NH, et al
    Neurosci Lett. 2020 Feb 11:134837. doi: 10.1016/j.neulet.2020.134837.
    PubMed     Abstract available

    January 2020
  109. GAO J, Teng J, Liu Z, Cai M, et al
    Association between vitamin D receptor polymorphisms and susceptibility to Parkinson's disease: An updated meta-analysis.
    Neurosci Lett. 2020;720:134778.
    PubMed     Abstract available

  110. SANNA A, Follesa P, Puligheddu M, Cannas A, et al
    Cerebellar continuous theta burst stimulation reduces levodopa-induced dyskinesias and decreases serum BDNF levels.
    Neurosci Lett. 2020;716:134653.
    PubMed     Abstract available

    December 2019
  111. HU W, Wang L, Chen B, Wang X, et al
    Vitamin D receptor rs2228570 polymorphism and Parkinson's disease risk in a Chinese population.
    Neurosci Lett. 2019;717:134722.
    PubMed     Abstract available

  112. BI M, Kang S, Du X, Jiao Q, et al
    Association between SNCA rs356220 polymorphism and Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2019;717:134703.
    PubMed     Abstract available

  113. SONG J, Lee SS, Lim S, Yeo S, et al
    Mechanism of the neuroprotective effect of injecting brain cells on ST36 in an animal model of Parkinson's disease.
    Neurosci Lett. 2019;717:134698.
    PubMed     Abstract available

    November 2019
  114. PARKHE A, Parekh P, Nalla LV, Sharma N, et al
    Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
    Neurosci Lett. 2019 Nov 25:134652. doi: 10.1016/j.neulet.2019.134652.
    PubMed     Abstract available

  115. LI X, Yang W, Li X, Chen M, et al
    Alpha-synuclein oligomerization and dopaminergic degeneration occur synchronously in the brain and colon of MPTP-intoxicated parkinsonian monkeys.
    Neurosci Lett. 2019 Nov 20:134640. doi: 10.1016/j.neulet.2019.134640.
    PubMed     Abstract available

  116. SEKAR S, Taghibiglou C
    Nuclear accumulation of GAPDH, GluA2 and p53 in Post-mortem Substantia Nigral region of Patients with Parkinson's Disease.
    Neurosci Lett. 2019 Nov 20:134641. doi: 10.1016/j.neulet.2019.134641.
    PubMed     Abstract available

  117. KATAYAMA T, Sawada J, Kikuchi-Takeguchi S, Kano K, et al
    Cerebrospinal fluid levels of alpha-synuclein, amyloid beta, tau, phosphorylated tau, and neuron-specific enolase in patients with Parkinson's disease, dementia with Lewy bodies or other neurological disorders: Their relationships with cognition and n
    Neurosci Lett. 2019 Nov 13:134564. doi: 10.1016/j.neulet.2019.134564.
    PubMed     Abstract available

  118. CHEN W, Yan X, Lv H, Liu Y, et al
    Gender differences in prevalence of LRRK2-associated Parkinson diseaseA meta-analysis of observational studies.
    Neurosci Lett. 2019 Nov 4:134609. doi: 10.1016/j.neulet.2019.134609.
    PubMed     Abstract available

    October 2019
  119. ZHANG Y, Chen J, Xu C, Feng J, et al
    Effects of glucocerebrosidase gene polymorphisms and mutations on the risk of Parkinson's disease dementia: a meta-analysis.
    Neurosci Lett. 2019 Oct 28:134544. doi: 10.1016/j.neulet.2019.134544.
    PubMed     Abstract available

  120. IWAOKA K, Otsuka C, Maeda T, Yamahara K, et al
    Impaired metabolism of kynurenine and its metabolites in CSF of Parkinson's disease.
    Neurosci Lett. 2019 Oct 22:134576. doi: 10.1016/j.neulet.2019.134576.
    PubMed     Abstract available

  121. FINE JM, Stroebel BM, Faltesek KA, Terai K, et al
    Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson's Disease.
    Neurosci Lett. 2019;714:134567.
    PubMed     Abstract available

    September 2019
  122. SHARMA S, Awasthi A, Singh S
    Altered Gut Microbiota and Intestinal Permeability in Parkinson's disease: Pathological highlight to Management.
    Neurosci Lett. 2019 Sep 24:134516. doi: 10.1016/j.neulet.2019.134516.
    PubMed     Abstract available

    August 2019
  123. XIE SP, Zhou F, Li J, Duan SJ, et al
    NEAT1 regulates MPP(+)-induced neuronal injury by targeting miR-124 in neuroblastoma cells.
    Neurosci Lett. 2019;708:134340.
    PubMed     Abstract available

  124. MORIYA S, Tan VP, Yee AK, Parhar IS, et al
    pink1, atp13a2 and uchl1 expressions are affected by inflammation in the brain.
    Neurosci Lett. 2019;708:134330.
    PubMed     Abstract available

    July 2019
  125. SHI K, Liu X, Hou L, Qiao D, et al
    Effects of exercise on mGluR-mediated glutamatergic transmission in the striatum of hemiparkinsonian rats.
    Neurosci Lett. 2019;705:143-150.
    PubMed     Abstract available

    June 2019
  126. RABENSTEIN M, Besong Agbo D, Wolf E, Dams J, et al
    Effect of naturally occurring alpha-synuclein-antibodies on toxic alpha-synuclein-fragments.
    Neurosci Lett. 2019;704:181-188.
    PubMed     Abstract available

    May 2019
  127. HERAVI M, Dargahi L, Parsafar S, Tayaranian Marvian A, et al
    The primary neuronal cells are more resistant than PC12 cells to alpha-synuclein toxic aggregates.
    Neurosci Lett. 2019;701:38-47.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.